The Italian vaccine research and advocacy organization Corvelva recently released new data regarding the use of aborted fetal cells in vaccines. The research reports the results produced from the MRC 5 cell line analysis, particularly the one contained in GlaxoSmithKline’s tetravalent measles-mumps-rubella-chickenpox (MMRV) vaccine.
Continue reading Here